Related Experiment Video
Updated: Nov 4, 2025

06:46
Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
521
Definite SUDEP population in Bexar County, Texas: A 36-year data registry.
Vahid Eslami1, D Kimberley Molina2, Charles Ákos Szabó3
1Department of Neurology, University of Health Science Center at San Antonio, TX, United States.
Epilepsy & Behavior : E&B
|May 30, 2021
Summary
Sudden unexplained death in epilepsy (SUDEP) is a major concern. This study found subtherapeutic anti-seizure medication levels in most SUDEP cases, suggesting nonadherence is a key risk factor.
Area of Science:
- Neurology
- Epileptology
- Forensic Pathology
Background:
- Sudden unexplained death in epilepsy (SUDEP) is a primary cause of mortality among individuals with epilepsy.
- Understanding SUDEP's risk factors is crucial for improving patient outcomes and reducing mortality rates.
Purpose of the Study:
- To investigate the incidence and characteristics of definite SUDEP cases in Bexar County over a 36-year period.
- To identify potential risk factors associated with SUDEP, including anti-seizure medication (ASM) levels and body mass index (BMI).
Main Methods:
- Review of death reports from the Bexar County Medical Examiner (BCME) between 1983 and 2018.
- Analysis of medical history, medication lists, sleep position, time of death, pathology reports, BMI, and organ weights.
- Comparison of SUDEP victims with therapeutic versus subtherapeutic ASM levels.
Main Results:
- 286 definite SUDEP cases were identified, with an incidence of 0.51 ± 0.26 per 1000 person-years in people with epilepsy.
- The majority of SUDEP victims (83.6%) had subtherapeutic ASM levels, indicating potential nonadherence.
- Elevated BMI was significantly associated with subtherapeutic ASM levels, suggesting a potential role for obesity in SUDEP.
Conclusions:
- Subtherapeutic ASM levels are a significant finding in autopsy-based SUDEP cases, highlighting nonadherence as a critical risk factor.
- Obesity, indicated by elevated BMI, may also contribute to SUDEP risk, particularly when associated with nonadherence to ASM therapy.
- Further case-controlled studies are recommended to confirm the specific roles of obesity and related comorbidities in SUDEP.
More Related Videos
Related Concept Videos
Epilepsy and Seizures: Overview
587
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
587
Seizures: Classification
847
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
847
Electroconvulsive Therapy
332
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
332

